Evidence for a cross-talk between human neutrophils and Th17 cells

Blood

Volumn 115, Issue 2, 2010, Pages 335-343

  Pelletier, Martin ^a   Maggi, Laura ^b   Micheletti, Alessandra ^a   Lazzeri, Elena ^b   Tamassia, Nicola ^a   Costantini, Claudio ^a   Cosmi, Lorenzo ^b   Lunardi, Claudio ^a   Annunziato, Francesco ^b   Romagnani, Sergio ^b   Cassatella, Marco A ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR6; CYTOKINE ANTIBODY; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 17RC; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CCL20 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; IL17F PROTEIN, HUMAN; IL17RC PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE; LEUKOCYTE ACTIVATION; MOLECULAR INTERACTION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUPERNATANT; SYNOVIAL FLUID; TH1 CELL; TH17 CELL; CELL COMMUNICATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HELPER CELL; IMMUNOLOGY; MALE; PATHOLOGY;

ARTHRITIS, RHEUMATOID; CELL COMMUNICATION; CHEMOKINE CCL2; CHEMOKINE CCL20; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-8; MALE; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, CCR2; RECEPTORS, CCR6; RECEPTORS, INTERLEUKIN; SYNOVIAL FLUID; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75649148842     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-216085     Document Type: Article

References (55)

1. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28(4):454-467.
2. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008; 223(1):87-113.
3. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 2008;41(4): 92-104.
4. Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem. 2006;281(47):35603-35607.
5. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204(8):1849-1861.
6. Cosmi L, De Palma R, Santarlasci V, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med. 2008;205(8):1903-1916.
7. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639-646.
8. Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol. 2008;180(1):122-129.
9. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol. 2008;180(1):214-221.
10. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180(11):7423-7430.
11. Hirota K, Yoshitomi H, Hashimoto M, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007; 204(12):2803-2812.
12. Scapini P, Laudanna C, Pinardi C, et al. Neutrophils produce biologically active macrophage in- flammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. Eur J Immunol. 2001; 31(7):1981-1988.
13. Yoshimura T, Takahashi M. IFN-gamma-mediated survival enables human neutrophils to produce MCP-1/CCL2 in response to activation by TLR ligands. J Immunol. 2007;179(3):1942-1949.
14. Gasperini S, Marchi M, Calzetti F, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gammainducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol. 1999;162(8):4928-4937.
15. Laan M, Prause O, Miyamoto M, et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J. 2003;21(3):387-393.
16. Dragon S, Saffar AS, Shan L, Gounni AS. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol Immunol. 2008;45(1): 160-168.
17. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4(9):e1000159.
18. Tamassia N, Le Moigne V, Calzetti F, et al. The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J Immunol. 2007;178(11):7344-7356.
19. Streeck H, Cohen KW, Jolin JS, et al. Rapid ex vivo isolation and long-term culture of human Th17 cells. J Immunol Methods. 2008;333(1): 115-125.
20. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colonystimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26(6):748-753.
21. Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol. 2004;173(3):2151-2158.
22. Shahrara S, Huang Q, Mandelin AM 2nd, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):R93.
23. Cross A, Bakstad D, Allen JC, Thomas L, Moots RJ, Edwards SW. Neutrophil gene expression in rheumatoid arthritis. Pathophysiology. 2005; 12(3):191-202.
24. Schlenk J, Lorenz HM, Haas JP, et al. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis. J Rheumatol. 2005;32(12):2291-2298.
25. Auer J, Blass M, Schulze-Koops H, et al. Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis. Arthritis Res Ther. 2007;9(5):R94.
26. Gerli R, Bistoni O, Russano A, et al. In vivo activated T cells in rheumatoid synovitis: analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol. 2002;129(3):549-555.
27. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556-567.
28. Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8(3):247-256.
29. Wolf K, Plano GV, Fields KA. A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signaling via interaction with human Act1. Cell Microbiol. 2009;11(5):769-779.
30. Qian Y, Qin J, Cui G, et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity. 2004;21(4):575-587.
31. Zhao L, Xu S, Fjaertoft G, Pauksen K, Hakansson L, Venge P. An enzyme-linked immunosorbent assay for human carcinoembryonic antigenrelated cell adhesion molecule 8, a biological marker of granulocyte activities in vivo. J Immunol Methods. 2004;293(1):207-214.
32. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5(14):1317-1327.
33. Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol. 1998;161(9):5027-5038.
34. Adib-Conquy M, Pedron T, Petit-Bertron AF, et al. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med. 2008;14(1): 36-44.
35. Liu LY, Bates ME, Jarjour NN, Busse WW, Bertics PJ, Kelly EA. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol. 2007;179(7): 4840-4848.
36. Webb A, Johnson A, Fortunato M, et al. Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists. J Leukoc Biol. 2008;84(4):1202-1212.
37. Wang C, Kang SG, Lee J, Sun Z, Kim CH. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2009;2(2):173-183.
38. Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol. 2008;181(7): 4733-4741.
39. Codolo G, Amedei A, Steere AC, et al. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum. 2008;58(11):3609- 3617.
40. Tateda K, Moore TA, Deng JC, et al. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol. 2001; 166(5):3355-3361.
41. Chen L, Watanabe T, Watanabe H, Sendo F. Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur J Immunol. 2001;31(1): 265-275.
42. Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic in-flux? Respir Res. 2006;7(1):135.
43. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology. 2009;136(1):247-256.
44. Sheibanie AF, Yen JH, Khayrullina T, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J Immunol. 2007;178(12):8138-8147.
45. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008;205(7):1535-1541.
46. Pease JE, Williams TJ. The attraction of chemokines as a target for specific anti-inflammatory therapy. Br J Pharmacol. 2006;147[suppl 1]:S212-S221.
47. Lindemann MJ, Hu Z, Benczik M, Liu KD, Gaffen SL. Differential regulation of the IL-17 receptor by gamma c cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem. 2008;283(20):14100-14108.
48. Yu JJ, Ruddy MJ, Wong GC, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007;109(9):3794-3802.
49. Kuestner RE, Taft DW, Haran A, et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol. 2007;179(8):5462-5473.
50. Ishigame H, Kakuta S, Nagai T, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30(1):108-119.
51. Freitas A, Alves-Filho JC, Victoni T, et al. IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol. 2009;182(12):7846-7854.
52. Kato T, Kitagawa S. Regulation of neutrophil functions by proinflammatory cytokines. Int J Hematol. 2006;84(3):205-209.
53. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3): 173-182.
54. Engeman T, Gorbachev AV, Kish DD, Fairchild RL. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol. 2004;76(5):941-949.
55. Scapini P, Nardelli B, Nadali G, et al. G-CSFstimulated neutrophils are a prominent source of functional BLyS. J Exp Med. 2003;197(3):297-302.